Viemed Healthcare, Inc. (VMD) Stock Forecast
VMD analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.50 / 5 from 2 analysts
- Price target
- $12.50 average of analyst targets
- Upside to target
- +31.9% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $0.12
- 52-week range
- $6.26 – $12.33
VMD analyst ratings
2 analystsNumber of analysts at each rating.
VMD price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
VMD earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.12 | $0.11 | $0.13 | $0.09 | +37.0% | 3 |
| Current fiscal year (2026) | $0.41 | $0.39 | $0.43 | $0.37 | +11.7% | 3 |
| Next fiscal year (2027) | $0.54 | $0.44 | $0.66 | $0.41 | +31.4% | 3 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
VMD revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $80.8M | $80.1M | $81.4M | +12.3% | 3 |
| Current fiscal year (2026) | $317.9M | $317.2M | $319.0M | +17.6% | 3 |
| Next fiscal year (2027) | $353.6M | $349.6M | $361.0M | +11.2% | 3 |
VMD EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
VMD revenue: reported and forecast
VMD EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.13 | $0.13 | $0.12 | $0.12 | $0.12 | −5.2% | 0 up · 0 down |
| Current fiscal year (2026) | $0.46 | $0.46 | $0.41 | $0.41 | $0.41 | −9.2% | 0 up · 1 down |
| Next fiscal year (2027) | $0.61 | $0.61 | $0.54 | $0.54 | $0.54 | −10.9% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
VMD earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; VMD beat in 6 of 12.
What analysts expect from VMD
2 analysts cover Viemed Healthcare; their consensus rating is buy (3.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $12.50, 31.9% above the latest close of $9.48. Analysts expect earnings of $0.41 per share for 2026, +11.7% from a year earlier. For 2027 the average estimate is $0.54 per share on revenue of $353.6 million. Viemed Healthcare beat the EPS estimate in 6 of the last 12 quarters.
Related: VMD income statement, VMD key metrics, VMD chart. See the VMD stock overview for the latest quote and news.
VMD forecast FAQ
What is Viemed Healthcare's price target?
The average analyst price target for Viemed Healthcare is $12.50, 31.9% above the latest close of $9.48.
Is Viemed Healthcare a buy, hold or sell?
Of 2 analysts covering Viemed Healthcare, 0 rate it a strong buy, 1 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Viemed Healthcare's EPS forecast?
Analysts forecast $0.41 per share for 2026 (range $0.39 to $0.43); for 2027 the estimate is $0.54.
What is Viemed Healthcare's revenue forecast?
The average revenue estimate for 2026 is $317.9 million, growth of 17.6%; for 2027 it is $353.6 million.
When does Viemed Healthcare report earnings?
Viemed Healthcare is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes; the EPS estimate is $0.12.
Does Viemed Healthcare usually beat earnings estimates?
Viemed Healthcare reported EPS at or above the analyst estimate in 6 of the last 12 quarters.